https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-11-01 / Int J Cancer 2020 01;146(2):531-541
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-11-01 / Int J Cancer 2020 01;146(2):531-5412019-11-01 00:00:002020-12-14 17:16:09Evaluation of Newcastle disease virus mediated dendritic cell activation and cross-priming tumor-specific immune responses ex vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-09-30 / Sci Rep 2019 Sep;9(1):13999
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-09-30 / Sci Rep 2019 Sep;9(1):139992019-09-30 00:00:002020-12-14 17:17:18Evaluation of a Recombinant Newcastle Disease Virus Expressing Human IL12 against Human Breast Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-09-27 / Front Mol Biosci 2019;6:90
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-09-27 / Front Mol Biosci 2019;6:902019-09-27 00:00:002020-12-14 17:15:172-Deoxyglucose and Newcastle Disease Virus Synergize to Kill Breast Cancer Cells by Inhibition of Glycolysis Pathway Through Glyceraldehyde3-Phosphate Downregulation
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-14 / Front Immunol 2019;10:1939
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-14 / Front Immunol 2019;10:19392019-08-14 00:00:002023-03-07 12:33:09Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-07-01 / In Vivo 2019 Jul-Aug;33(4):983-997
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-07-01 / In Vivo 2019 Jul-Aug;33(4):983-9972019-07-01 00:00:002019-07-01 00:00:00Chemoprevention of Breast Cancer With Vitamins and Micronutrients: A Concise Review
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-06-14 / Br J Clin Pharmacol 2019 Aug;85(8):1670-1683
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-06-14 / Br J Clin Pharmacol 2019 Aug;85(8):1670-16832019-06-14 00:00:002023-03-07 12:45:44Assessing the impact of the addition of dendritic cell vaccination to neoadjuvant chemotherapy in breast cancer patients: A model-based characterization approach
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-08 / EBioMedicine 2019 May;43:201-210
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-08 / EBioMedicine 2019 May;43:201-2102019-04-08 00:00:002019-04-08 00:00:00Vitamin C supplementation expands the therapeutic window of BETi for triple negative breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-04 / BMC Cancer 2019 Apr;19(1):315
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-04 / BMC Cancer 2019 Apr;19(1):3152019-04-04 00:00:002020-12-14 17:17:19Regression of solid breast tumours in mice by Newcastle disease virus is associated with production of apoptosis related-cytokines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-02-01 / 2019 Feb;39(2):751-758
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-02-01 / 2019 Feb;39(2):751-7582019-02-01 00:00:002020-10-05 10:14:54Effect of High-dose Vitamin C Combined With Anti-cancer Treatment on Breast Cancer Cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-01-01 / Crit Rev Immunol 2019;39(3):211-221
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-01-01 / Crit Rev Immunol 2019;39(3):211-2212019-01-01 00:00:002019-01-01 00:00:00Immunotherapy for Triple-Negative Breast Cancer: Latest Research and Clinical Prospects
